RECRUITING

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.

Official Title

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients: a Randomized, Observer-Blinded, Prospective Clinical Trial

Quick Facts

Study Start:2020-06-15
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04164173

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 years and older
  2. 2. Admitted to Cardiovascular ICU (CVICU) after coronary artery bypass grafting (CABG), isolated valve repair/replacement, or CABG + valve repair/replacement
  3. 3. Cardiac surgery performed via median sternotomy
  1. 1. BMI\>40
  2. 2. Refusal to be consented
  3. 3. Prior or current lung transplant patients

Contacts and Locations

Study Contact

Jaffer Odeh, MD
CONTACT
214-786-1067
Jaffer.Odeh@UTSouthwestern.edu
Emily Melikman, RN
CONTACT
214-645-7011
Emily.Melikman@UTSouthwestern.edu

Principal Investigator

Jaffer Odeh, MD
STUDY_CHAIR
UT Southwestern Medical Center

Study Locations (Sites)

UT Southwestern Clements University Hospital
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • Jaffer Odeh, MD, STUDY_CHAIR, UT Southwestern Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-06-15
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2020-06-15
Study Completion Date2027-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Pulmonary Disease
  • Postoperative Complications